01.03.2002 | Original Article
Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 3/2002
Einloggen, um Zugang zu erhaltenAnzeige